For instance, HLA-A*02:05 and HLA-A*03:01 are protective against severe clinical manifestations of SARS-CoV-2 (Littera et al., 2020; Shkurnikov et al., 2021), DRB1*01:01 is protective against MS (Mamedov et al., 2020), and DRB1*11:02 protects against rheumatoid arthritis (Cruz-Tapias et al., 2013). This evidence concerns the gene HLA-A and myeloid sarcoma.